Prevalence of Selected Complementary Health Approaches High in Seniors

THURSDAY, April 30, 2026 (HealthDay News) -- Use of selected complementary health approaches (CHA) is high among older adults, according to a study published online April 24 in the American Journal of Medicine.Dennis Muñoz-Vergara, D.V.M., M.P.H., from the Osher Center for Integrative Health at Brigham and Women's Hospital in Boston, and colleagues conducted cross-sectional analyses of the COSMOS Study 2024 survey, which asked participants about their use of and interest in CHA: manual therapies, mind-body therapies, herbal products, acupuncture, spiritual practices, and cannabis/psychedelics. Key baseline sociodemographic, lifestyle, and clinical characteristics were compared between CHA users and nonusers overall and for each category.Of the 16,144 respondents (median age, 77.5 years), 58.8 percent indicated using CHA at least once in the past 12 months and 76.4 percent reported ever in lifetime use; 50.4 percent reported interest in participating in CHA research. The researchers found the highest prevalence of recent use and lifetime use for spiritual practices (38.6 percent) and manual therapies (51.9 percent), respectively. Higher odds of recent and lifetime CHA use were seen in association with a history of falls or depression."There may be a disconnect between what patients are doing and what health care providers realize," senior author Howard D. Sesso, Sc.D., M.P.H., also from the Osher Center, said in a statement. "Patients often seek to supplement their doctors' recommended treatments. I hope this study opens the eyes of the health care community to talk to their patients about complementary and integrative health modalities."Abstract/Full Text (subscription or payment may be required).Sign up for our weekly HealthDay newsletter

Prevalence of Selected Complementary Health Approaches High in Seniors

Related Stories

Gap Found Between Awareness of Breast Cancer Risk and Risk-Reducing Behavior

2018 to 2025 Saw Sharp Rise in Postpartum GLP-1 Receptor Agonist Use

ASTRO: <30 Percent With ER+ Early-Stage Breast Cancer Remain on Endocrine Therapy at Five Years

Focused Brain Radiation Could Ease Severe, Tough-To-Treat Depression